Zulfa Omer
Clinical trials sponsored by Zulfa Omer, explained in plain language.
-
New drug combo aims to send blood cancer into deeper remission
Disease control Recruiting nowThis study is testing if adding a new drug called epcoritamab to standard therapy can help patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. The goal is to see if this combination can eliminate nearly all detectable c…
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Apr 04, 2026 02:06 UTC
-
Trial tests less frequent dosing for blood cancer treatment
Disease control Recruiting nowThis study is testing whether taking one of two drugs less often works as well as taking it continuously for people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). About 62 participants will be randomly assigned to receive the dru…
Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC